Jan 2, 2026
How do Medicare Advantage prior authorization rules affect access to Leqembi and donanemab?
Medicare’s national coverage determinations mean FDA‑approved amyloid‑targeting drugs such as Leqembi (lecanemab) and donanemab are eligible for Medicare payment, but Medicare Advantage plans frequent...